Keyphrases
Human Leukocyte Antigen
100%
Bile Acids
86%
Abacavir
85%
Drug-induced
66%
Idiosyncratic Drug Toxicity
56%
Sandwich-cultured Hepatocytes
56%
Transgenic Mice
52%
Human Leukocyte antigen-B
51%
Hepatocyte Toxicity
40%
Assay System
40%
Bile Salt Export Pump
39%
Hepatotoxicity
37%
Drug-induced Liver Injury
35%
Cholestatic Liver Injury
35%
CD8+ T Cells
27%
Cyclosporine
26%
Multidrug Resistance Protein
25%
Hepatic Uptake
23%
Acid Accumulation
23%
Injury Risk
22%
Efflux
21%
Abacavir Hypersensitivity
20%
Skin Toxicity
19%
Liver Injury
18%
Dendritic Cells
18%
Inhibitory Pathways
18%
Transgenic
18%
DPP8
18%
Induced Pluripotent Stem Cell-derived Hepatocytes
18%
Knock-in Mouse Model
18%
Glucuronide
18%
Toxicity Assay
18%
Mechanism-based
18%
Clinical Risk
18%
Immune Response
18%
HepaRG Cells
18%
Organic Anions
18%
Induced Pluripotent Stem Cells (iPSCs)
18%
Selective Inhibitor
18%
Rat Hepatocytes
18%
Hematological Malignancies
18%
Immune Tolerance
18%
Wild-type Rats
18%
Anticancer Agents
18%
Cell Toxicity
18%
Tolerance System
18%
Tg Mouse
18%
Skin Hypersensitivity
15%
Bile Canaliculi
14%
Programmed Death-ligand 1 (PD-L1)
14%
Pharmacology, Toxicology and Pharmaceutical Science
Leukocyte Antigen
86%
Bile Acid
85%
Abacavir
67%
Toxic Hepatitis
63%
Drug Toxicity
56%
Transgenic Mouse
44%
Bile Salt Export Pump
39%
Liver Injury
37%
Cytotoxicity
37%
Hepatotoxicity
36%
Effusion
31%
Multidrug Resistance-Associated Protein 2
28%
Ciclosporin
27%
CD8 Antigen
26%
Skin Toxicity
19%
Glucuronide
18%
Anticarcinogen
18%
Wild Type Rat
18%
Hematologic Malignancy
18%
Raloxifene
18%
Biliary Excretion
14%
Pyroptosis
12%
Messenger RNA
12%
Deoxycholic Acid
12%
Erethism
12%
Programmed Death 1 Receptor
11%
Taurocholic Acid
10%
Adverse Drug Reaction
10%
Neoplasm
9%
Immunogenicity
9%
Sprague Dawley Rat
9%
Allergic Reaction
9%
Chenodeoxycholic Acid
9%
Alkaline Phosphatase
7%
Aminotransferase
7%
Malignant Neoplasm
7%
Myeloma
6%
Antitumor Activity
6%
Caspase 3
6%
Medicine and Dentistry
Abacavir
37%
Human Leukocyte Antigen
37%
Hepatocyte
37%
Bile Acid
37%
Multidrug Resistance Associated Protein 2
25%
Liver Toxicity
22%
In Vitro
21%
Glucuronide
18%
Liver Injury
18%
Toxicity Assay
18%
Raloxifene
18%
Induced Pluripotent Stem Cell
18%
Skin Toxicity
18%
Immunological Tolerance
18%
Drug Toxicity
17%
Toxic Hepatitis
17%
Cytotoxic T-Cell
17%
T Cell
13%
Bile Salt Export Pump
12%
Biliary Excretion
12%
T-Helper Cell
12%
Programmed Death 1 Receptor
11%
Hypersensitivity
11%
Tumor Progression
10%
Chimeric Antigen Receptor T-Cell Immunotherapy
9%
Neoplasm
9%
Cancer Model
9%
Immune Response
9%
Caloric Restriction
9%
Bile Canaliculus
9%
Cancer
9%
Messenger RNA
9%
Effusion
8%
Adverse Drug Reaction
5%
Transgenic Mouse
5%
Cyclosporine
5%